Skip Navigation

JNCI Monographs 2003 2003(31):35-40;
© 2003 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Wang, S. S.
Right arrow Articles by Hildesheim, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, S. S.
Right arrow Articles by Hildesheim, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute Monographs, No. 31, 35-40, 2003
© 2003 Oxford University Press

ARTICLE

Chapter 5: Viral and Host Factors in Human Papillomavirus Persistence and Progression

Sophia S. Wang, Allan Hildesheim

Affiliation of authors: Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.

Correspondence to: Sophia S. Wang, Ph.D., National Cancer Institute, National Institutes of Health, 6120 Executive Blvd., EPS MSC 7234, Bethesda, MD 20892-7234 (e-mail: wangso{at}mail.nih.gov).

Understanding the interdependent roles that host and viral factors play in cervical cancer pathogenesis is important for distinguishing women at the highest risk of human papillomavirus (HPV) persistence and progression to cervical cancer. Ongoing research on viral factors such as viral variants is providing important clues regarding HPV oncogenesis; the comprehensive characterization of the HPV genome and the function of viral genes by HPV type and variant will further this understanding. Although the biologic importance of viral integration and viral load measurements in cervical neoplasia is still being debated, available data are difficult to interpret because of methodologic limitations; to sufficiently address the importance of these events will require further methods validation and subsequent application in epidemiologic studies. Continued and expanded investigation of host immune responses—humoral, cellular, and innate immunity—should specifically address the outcomes of HPV persistence and progression to cervical cancer. Molecularly based assays paired with functional assays will be integral toward the identification and validation of key immune pathways and genes specifically relevant to cervical cancer pathogenesis. Novel technologies such as gene expression microarrays will further allow comprehensive identification of relevant genes that are important at various stages of cervical pathogenesis. The study of viral and host factors will undoubtedly lead to markers that may hold diagnostic and/or prognostic value; the clinical validity and utility of these molecular events will, therefore, need to be carefully assessed before implementation in a population setting.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Gen. Virol.Home page
N. Azizi, J. Brazete, C. Hankins, D. Money, J. Fontaine, A. Koushik, A. Rachlis, K. Pourreaux, A. Ferenczy, E. Franco, et al.
Influence of human papillomavirus type 16 (HPV-16) E2 polymorphism on quantification of HPV-16 episomal and integrated DNA in cervicovaginal lavages from women with cervical intraepithelial neoplasia
J. Gen. Virol., July 1, 2008; 89(7): 1716 - 1728.
[Abstract] [Full Text] [PDF]

Home page
 J. Gen. Virol.Home page
M. L. Tornesello, M. L. Duraturo, P. Giorgi-Rossi, M. Sansone, R. Piccoli, L. Buonaguro, and F. M. Buonaguro
Human papillomavirus (HPV) genotypes and HPV16 variants in human immunodeficiency virus-positive Italian women
J. Gen. Virol., June 1, 2008; 89(6): 1380 - 1389.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Z. Zhang, I. Borecki, L. Nguyen, D. Ma, K. Smith, P. C. Huettner, D. G. Mutch, T. J. Herzog, R. K. Gibb, M. A. Powell, et al.
CD83 Gene Polymorphisms Increase Susceptibility to Human Invasive Cervical Cancer
Cancer Res., December 1, 2007; 67(23): 11202 - 11208.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
C. E. Wood, Z. Chen, J. M. Cline, B. E. Miller, and R. D. Burk
Characterization and Experimental Transmission of an Oncogenic Papillomavirus in Female Macaques
J. Virol., June 15, 2007; 81(12): 6339 - 6345.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. T. Goodman, Y. B. Shvetsov, K. McDuffie, L. R. Wilkens, X. Zhu, A. A. Franke, C. C. Bertram, B. Kessel, M. Bernice, C. Sunoo, et al.
Hawaii Cohort Study of Serum Micronutrient Concentrations and Clearance of Incident Oncogenic Human Papillomavirus Infection of the Cervix
Cancer Res., June 15, 2007; 67(12): 5987 - 5996.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. A. de Boer, E. S. Jordanova, G. G. Kenter, A. A. Peters, W. E. Corver, J. B. Trimbos, and G. J. Fleuren
High Human Papillomavirus Oncogene mRNA Expression and Not Viral DNA Load Is Associated with Poor Prognosis in Cervical Cancer Patients
Clin. Cancer Res., January 1, 2007; 13(1): 132 - 138.
[Abstract] [Full Text] [PDF]

Home page
 J. Histochem. Cytochem.Home page
B. Albarran-Somoza, R. Franco-Topete, V. Delgado-Rizo, F. Cerda-Camacho, L. Acosta-Jimenez, M. Lopez-Botet, and A. Daneri-Navarro
CEACAM1 in Cervical Cancer and Precursor Lesions: Association With Human Papillomavirus Infection
J. Histochem. Cytochem., December 1, 2006; 54(12): 1393 - 1399.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
T. S. Shields, L. A. Brinton, R. D. Burk, S. S. Wang, S. J. Weinstein, R. G. Ziegler, Y. Y. Studentsov, M. McAdams, and M. Schiffman
A Case-Control Study of Risk Factors for Invasive Cervical Cancer among U.S. Women Exposed to Oncogenic Types of Human Papillomavirus
Cancer Epidemiol. Biomarkers Prev., October 1, 2004; 13(10): 1574 - 1582.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.